(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 22.9% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.18%.
Ceribell's revenue in 2025 is $77,419,000.On average, 9 Wall Street analysts forecast CBLL's revenue for 2025 to be $3,249,967,451, with the lowest CBLL revenue forecast at $3,115,190,705, and the highest CBLL revenue forecast at $3,356,952,910. On average, 9 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,165,760,044, with the lowest CBLL revenue forecast at $3,898,479,717, and the highest CBLL revenue forecast at $4,462,004,906.
In 2027, CBLL is forecast to generate $5,464,031,151 in revenue, with the lowest revenue forecast at $5,048,261,754 and the highest revenue forecast at $5,943,962,492.